Last updated 2026-06-18
- Raised funding round, May 2021
Total raised
—
Last: 2021-05
Stage
Seed
Founded
2021
Headcount
4
HQ
, Israel
Sector
Health Tech & Life Sciences
About
Skip Therapeutics develops personalized RNA-based treatments for rare genetic diseases in directly identified patients and patient cohorts using a novel, proprietary computational engine. The companys bioinformatic pipeline analyzes disease-causing mutations and recognizes the best available molecular strategy to restore protein function using splice-modulating antisense oligonucleotides (ASOs). The analysis of mutation data at scale enables identification of treatable patient cohorts and optimizes target selection, with top candidates from the computational analyses experimentally validated and pursued for therapeutic development. Skip Therapeutics operates from the FutuRx biotech incubator.
Funding history · 1 round · — total
2021-05
Q&A
- What is Skip Therapeutics' primary focus?
- Skip Therapeutics focuses on developing personalized RNA-based treatments for rare genetic diseases, utilizing a proprietary computational engine to identify treatable patient cohorts and optimize target selection.
- When was Skip Therapeutics founded?
- Skip Therapeutics was founded in January 2021.
- What is the current status of Skip Therapeutics?
- Skip Therapeutics is currently non-active and ceased to operate in July 2026.
- How many employees does Skip Therapeutics have?
- Skip Therapeutics has 1-10 employees.
- Which investors participated in Skip Therapeutics' funding round in May 2021?
- In May 2021, RMGP Biopharma Investment Fund and FutuRx participated in a funding round for Skip Therapeutics.
- Who is a co-founder and CSO of Skip Therapeutics?
- Ariel Feiglin is a co-founder and CSO of Skip Therapeutics.
- Where is Skip Therapeutics headquartered?
- Skip Therapeutics is headquartered in Ness Ziona, Israel.
- What is Skip Therapeutics' primary sector?
- Skip Therapeutics' primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMoleculesGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B
Tags
pharmaceuticalsbiotechnologytreatmentsprecision-medicinebioinformaticsdrug-discoverygenetic-disorderspersonalizationrare-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/74985481 |
Identifiers & details
| Founded | 2021-1 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | skiptx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|